
TWST Stock Forecast & Price Target
TWST Analyst Ratings
Bulls say
Twist Bioscience is positioned to capitalize on the rapidly growing synthetic biology market with its disruptive DNA synthesis platform, strong customer base, and expanding geographic reach. The company has demonstrated strong financials, with a significant portion of its revenues coming from the lucrative NGS segment. Additionally, the company's focus on cost efficiency and operational scale provides a clear path to higher gross margins and profitability, making it an attractive investment for long-term growth potential.
Bears say
Twist Bioscience is experiencing significant momentum in their NGS segment, and the company's growing focus on artificial intelligence (AI) is expected to drive continued revenue growth over the coming quarters. However, there are two key risks to this positive outlook: potential competition in the NGS market and any slowdown in NGS momentum. Additionally, while the company's AI-driven orders are currently driving growth, there is potential for this to be a sustained demand driver in the future.
This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.
TWST Analyst Forecast & Price Prediction
Start investing in TWST
Order type
Buy in
Order amount
Est. shares
0 shares